Background
Initially working in mental health and homelessness service provision in Australia and the UK, Daniel moved into public health research in 2010 after joining Burnet Institute.
Since then, Daniel has fostered strong research skills in program development and leadership, field research and programmatic evaluation, particularly in the areas of alcohol and other drug research and viral hepatitis elimination.
Qualifications
- 2018: Doctor of Philosophy (Public Health)
- 2012: Master of Public Health (International Health)
- 2004: Bachelor of Behavioural Science
Positions
- 2021: Senior Project Officer, Burnet Institute
- 2019-2021: Research and Technical Advisor, Burnet Institute Myanmar Office
- 2018-2019: Data Analyst Activity Manager, Médecins Sans Frontières
- 2014-2018: PhD Candidate, Monash University
- 2010-2013: Research Assistant, Burnet Institute
Burnet publications
View 38 moreIndividual-level harm reduction intervention coverage among people in Australia who inject drugs
International Journal of Drug Policy
Olivia Price et al
Supervised Injecting Room Cohort Study (SIRX): study protocol
BMJ Open
Ashleigh C. Stewart et al
Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocol
BMJ Open
Filip Djordjevic et al
Past projects
Eliminate C (EC) Victoria partnership
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.
ACCESS Myanmar: Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar
ACCESS Myanmar will implement and evaluate an electronic health records data linkage system that effectively monitors the progress of patients through HIV testing and treatment episodes of care across a network of partnering community and government services.